Price to Book ratio Analysis of Acrivon Therapeutics Inc. - Deep Dive
Latest FY PB
Period Ending - Dec-23
Very Poor PB
1406.36
Period Ending - Dec-22
Very Good PB
0.993
Growth
141574 %
Trailing Twelve Months PB
Period Ending - Dec-23
Very Poor PB
314.14
Most recent Quarter PB
Period Ending - Mar-24
Good PB
1.62
PB Analysis of Acrivon Therapeutics Inc.
P/B Ratio of Acrivon Therapeutics Inc. with value of 314.14 shows that company is trading much above Book value and may be risky. |
PB Ratio of ACRV rose handsomely by 141574 % this year. |
Other PB Related Info of ACRV that may interest you.
Acrivon Therapeutics Inc. Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
ACRV | 7.72 | 7.57 | 1.98 % | Biotechnology |
Defination of Price to Book
Price to book value essentially determines the value given by the market for each rupee of the company's net worth. Book value refers to how much an investor would receive if the company sold off its assets and paid all its debts. Book value shows the actual value of the company. more ..PB Related Ratios
PriceToEarningRatio | PriceToSalesRatio | ReturnOnEquity |
Tsr Value Index
Poor Value Stock |
FY - Historical Price to Book of Acrivon Therapeutics Inc.
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 |
---|---|---|---|---|
PB | 1406.36 | 0.993 | -4.18 | -11.82 |
Change | 141574 % | 123.76 % | 64.66 % |
FY Chart of Price to Book of Acrivon Therapeutics Inc.
Note : All Data Generated at the End of Trading Hours (EOD Data)